By API User
AdAlta Limited, the clinical stage drug discovery company developing novel therapeutic products to treat challenging diseases in fibrosis and oncology today announced their support of Bill Van Nierop’s Long Kayak for Lungs 2. The 1400km kayak, which seeks to raise much-needed funds for lung disease research, will see 70 year old double lung transplant … Continued
By API User
Cleo Diagnostics (ASX:COV) lists on the ASX today aiming to bring to market a simple blood test for the accurate and early diagnosis of ovarian cancer, based on the novel patented CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but not in non-malignant disease. The test aims to distinguish benign … Continued
By API User
In-depth Analysis and Testing Unveil the Leading Brain-Boosting Supplements LONDON, ENGLAND / ACCESSWIRE / August 17, 2023 / WholisticResearch, a leading authority in the realm of cognitive enhancement research, has recently unveiled its list of the top nootropic supplements for 2023. Following rigorous testing and comprehensive analysis, the organization has identified the most effective cognitive … Continued
By API User
A research team led by engineers and cardiologists from Monash University has used artificial intelligence (AI) to develop an algorithm to accurately predict the survival of intensive care patients who need external heart-lung support (ECMO). The ECMO Predictive Algorithm or “ECMO PAL” is the first AI-powered ECMO survival score trained and validated on a large … Continued
By API User
AEGROS today announced a ground-breaking agreement to build a fully funded US$400m 1,000,000 litre HaemaFrac® plasma fractionation facility in Singapore, with a sterile fill and finish facility in Cambodia, to supply the Asian market, using local plasma. The joint venture, to be called the Royal Group Plasma Fractionation (RGPF), was formed between The Royal Group … Continued
By API User
OMO-103 in Phase 1b clinical trial BARCELONA, SPAIN / ACCESSWIRE / July 27, 2023 / Peptomyc S.L., a biotech company specialized in the development of protein therapeutics for cancer treatment, announces that it has received full study approval for its new Phase 1b clinical trial, which will evaluate the combination of the first-in-class MYC inhibitor, … Continued
By API User
HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA TAIPEI, TAIWAN and SAN FRANCISCO, CA / ACCESSWIRE / July 24, 2023 / HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate … Continued
By API User
BIRMINGHAM, AL / ACCESSWIRE / July 24, 2023 / BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Ready™ PCR assay* for detection of Candida auris, a rapidly spreading, hard to treat fungus with a growing presence in hospitals and long-term care facilities. A complete PCR mix is … Continued
By API User
Monash University-led research into growing human brain cells onto silicon chips, with new continual learning capabilities to transform machine learning, has been awarded almost $600,000 AUD in the prestigious National Intelligence and Security Discovery Research Grants Program. The new research program, led by Associate Professor Adeel Razi, from the Turner Institute for Brain and Mental … Continued
By API User
Sydney 19 July 2023 In a ground-breaking first-to-market initiative, Allied BioServices has launched a revolutionary new mould remediation service which will see the business partner with residential property owners and managers to eliminate harmful mould from homes. The service, which leverages a cutting-edge, long-lasting non-toxic coating technology, responds to the growing incidence of concern … Continued
